Roche Applied Science Introduces new xCELLigence RTCA MP Instrument
News Dec 05, 2008
Following the launch of the xCELLigence RTCA SP Instrument in June, Roche Applied Science has introduced the new xCELLigence RTCA MP Instrument.
In comparison with the RTCA SP, the new RTCA MP Instrument has a higher throughput capacity and is versatile which enables application on a wider range of experimental set-ups.
The system features six E-Plates 96 as opposed to only one in the RTCA SP. Each E-Plate can be individually addressed in independent experiments.
The heart of each xCELLigence System is a micro-electronic biosensor which is built into each well of the standard 96 well E Plate microtiter plates. A cell which has contact with the sensor changes the electrical impedance between the microelectrodes. Each change in the cell’s status leads to changes in the impedance measurements and can therefore be easily detected in real time. Labelling of the cells, which can induce non-physiological changes in the cells, is not necessary. The system is label free and requires no reporters.
XenoGesis and BioAscent Forge Alliance to Offer Enhanced Integrated Drug Discovery ServicesNews
XenoGesis and BioAscent Discovery Limited have announced a collaboration to offer an enhanced range of integrated drug discovery services, including medicinal chemistry, biology and DMPK.READ MORE
BioAscent Establishes Integrated Drug Discovery Services OfferingNews
Dr Phil Jones to join as new CSO to lead company’s extended capabilities in medicinal chemistry and in vitro biosciences.READ MORE
Lab Innovations returns to the NEC, Bimingham , UKNews
Save the date for the UK’s only lab-dedicated exhibition showcase!READ MORE
Comments | 0 ADD COMMENT
International Conference on Biobetters and Regulatory Affairs
Jun 27 - Jun 28, 2018